SpaceX bars China and Hong Kong investors from $75B IPO…

Underwriters for SpaceX's $75 billion IPO have been instructed to reject subscription orders from investors in mainland China and Hong Kong — including private banking clients — citing regulatory and compliance risks tied to U.S. restrictions on critical technology exports. The directive was communicated directly to banks participating in the underwriting syndicate, according to Bloomberg.

Why it matters

The exclusion reflects how aggressively U.S. export-control frameworks are now being applied upstream, before a company even lists publicly. SpaceX operates deep inside the U.S. defense and space infrastructure stack — its Starlink network, Falcon rockets, and Starship program all carry national-security sensitivities that make Chinese capital participation a non-starter under current ITAR and EAR regimes. The move signals that the technology decoupling between the U.S. and China is no longer confined to trade policy or chip sanctions; it is now shaping who can own equity in the most valuable private companies on earth.

Market impact

For Asian wealth managers and private banks with significant mainland and Hong Kong client books, the exclusion closes off one of the most anticipated pre-IPO allocations in years. Broader market read: any future IPO touching defense, space, AI, or advanced semiconductors is likely to face the same gatekeeping — investors in restricted jurisdictions should price in systematic exclusion from the highest-profile U.S. tech listings going forward.